Senate panel to scrutinize proposed Bayer-Monsanto merger

WASHINGTON (AP) – The Senate is set to take a closer look at a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer. The deal combines two of the six U.S. and European companies that dominate the agrochemical market, and would create a global agricultural…